Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationHematologic NeoplasmsTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Blood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseMyeloablative AgonistsBusulfanTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisCord Blood Stem Cell TransplantationHodgkin DiseaseHematopoiesisCytarabineStem CellsDisease-Free SurvivalRetrospective StudiesNeoplasmsTransplantation ChimeraTissue DonorsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsLeukemiaInfectionLymphoma, T-CellHistocompatibilityDoxorubicinPlatelet CountHistocompatibility TestingPOEMS SyndromeImmunosuppressive AgentsLeukemia, Myeloid, AcutePrednisoneVidarabineLymphomaCarboplatinAntineoplastic AgentsFollow-Up StudiesTransplantation, IsogeneicDexamethasoneProspective StudiesRecombinant ProteinsBlood Cell CountGraft vs Leukemia EffectBlood CellsBone Marrow PurgingFatal OutcomeCytomegalovirus InfectionsMyelodysplastic SyndromesFeasibility StudiesImmunophenotypingAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionLiver TransplantationHematologic DiseasesPrognosisBlood Transfusion, AutologousT-LymphocytesBone MarrowCyclosporineHLA AntigensLeukocytes, MononuclearHistiocytosis, Non-Langerhans-CellLivedo ReticularisBlood DonorsImmunosuppressionBreast NeoplasmsFeverFlow Cytometry